UPS delivered its Q2 results on July 28 and the market punished the print — shares fell 6.6% on the day and are down 9.3% on the week to $105.53, unwinding much of the bullish options setup that had built ahead of the release.
The reversal is particularly striking given where positioning sat heading in. The pre-earnings note published here on July 25 flagged the put/call ratio at its most bullish level of the past year — a 2.4 standard deviation tilt toward calls. That optimism has since faded sharply. The PCR has now rebounded to 0.78, nearly 1.8 standard deviations below its 20-day mean of 0.84 — meaning the ratio moved back toward neutral rather than staying euphoric. Call buyers from last week are underwater, and the options market is no longer leaning bullish.
Short interest tells a moderately more cautious story than the price action alone might suggest. Bears were not crowded heading into the print — SI was running at 3.2% of the free float, near its lowest in six weeks, having shed roughly 11% from late-June peaks. In the two days since earnings, SI has ticked up modestly, adding around 0.2% on the day. But at 3.2% of float, with borrow availability at a vast 1,956% and cost to borrow holding near 0.40%, there is no squeeze dynamic here. The lending market is loose by any measure — shares available to borrow dwarf those already lent out by a factor of roughly nineteen — and that gap makes it easy for fresh shorts to enter if sentiment continues to deteriorate.
The Street's response to the print has been swift but not panicked. Most firms that moved on Tuesday maintained their ratings while adjusting targets around the new price reality. UBS kept its Buy and nudged its target up to $124. Oppenheimer held Outperform at $117. Stifel maintained Buy with a $115 target. Stephens was the outlier — the lone cut, trimming its Overweight target to $130 from $135. BMO lifted its Market Perform target to $115 from $110, suggesting limited conviction in either direction. The consensus mean target now sits at $115.85, implying roughly 10% upside from Tuesday's close — a gap that has opened up almost entirely in one session. The factor score for analyst recommendation divergence ranks in the 90th percentile, reflecting unusually wide disagreement across the sell-side on what the stock is worth. The dividend yield score ranks in the 85th percentile, a reminder that at $105 the income case looks more compelling than it did a week ago.
Bulls point to UPS's unmatched global network, 22 million daily packages, and ongoing cost-savings execution as reasons to look through near-term softness. The 12-month forward EPS growth score ranks in the 72nd percentile, and margin expansion through SMB and Healthcare mix shift remains the core long thesis. Bears counter with real concerns: volume pressure from the loss of a major customer, USD/EUR headwinds, rising competition, and a macro backdrop that keeps ground parcel pricing under pressure. The P/E has compressed to 13.8x on the week — down 1.4 turns — and EV/EBITDA has fallen to 8.6x, off 0.5 turns in a single session. Against that, FDX managed a 0.6% gain on Tuesday, and GXO ended the week down only 1.4%, underscoring that the UPS selloff was stock-specific rather than a sector-wide repricing.
The next scheduled catalyst is Q3 earnings on October 27. Between now and then, the key variables to watch are whether short interest continues to rebuild from its current relatively modest base, how quickly the options market reprices its neutral-to-bearish reset, and whether any of the major Buy-rated analysts revisit their $120-plus targets after digesting the full Q2 commentary.
See the live data behind this article on ORTEX.
Open UPS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
